TrialJournal of diabetes investigation2017

Insulin degludec/insulin aspart vs biphasic insulin aspart 30 twice daily in Japanese patients with type 2 diabetes: A randomized controlled trial.

Yukiko Onishi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.